Erythromycin Lactobionate is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Exela Pharma Sciences, Llc. The primary component is Erythromycin Lactobionate.
| Product ID | 51754-7000_e69b3024-f4bd-456e-8c74-2f9bc33739c9 |
| NDC | 51754-7000 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Erythromycin Lactobionate |
| Generic Name | Erythromycin Lactobionate |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-03-15 |
| Marketing Category | ANDA / |
| Application Number | ANDA211086 |
| Labeler Name | Exela Pharma Sciences, LLC |
| Substance Name | ERYTHROMYCIN LACTOBIONATE |
| Active Ingredient Strength | 500 mg/10mL |
| Pharm Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |